Survival-strategies of endophytic Fusarium solani against indigenous camptothecin biosynthesis

Fungal Ecology

Volumn 4, Issue 3, 2011, Pages 219-223

  Kusari, Souvik ^a   Košuth, Ján ^b   Čellárová, Eva ^b   Spiteller, Michael ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Camptothecin; Endophytic fungus; Fusarium solani; Survival strategy; Topoisomerase I

Indexed keywords

FUNGI; FUSARIUM SOLANI;

EID: 79953026004     PISSN: 17545048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.funeco.2010.11.002     Document Type: Article

References (26)

1. Chillemi G., Fiorani P., Benedetti P., Desideri A. Protein concerted motions in the DNA-human topoisomerase I complex. Nucleic Acids Research 2003, 31:1525-1535.
2. Chrencik J.E., Staker B.L., Burgin A.B., Pourquier P., Pommier Y., Stewart L., Redinbo M.R. Mechanisms of camptothecin resistance by human topoisomerase I mutations. Journal of Molecular Biology 2004, 339:773-784.
3. D'Costa V.M., McGrann K.M., Hughes D.W., Wright G.D. Sampling the antibiotic resistome. Science 2006, 311:374-377.
4. Eyberger A.L., Dondapati R., Porter J.R. Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin. Journal of Natural Products 2006, 69:1121-1124.
5. Fiorani P., Bruselles A., Falconi M., Chillemi G., Desideri A., Benedetti P. Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I. Journal of Biological Chemistry 2003, 278:43268-43275.
6. Fujimori A., Harker W.G., Kohlhagen G., Hoki Y., Pommier Y. Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Research 1995, 55:1339-1346.
7. Hopwood D.A. How do antibiotic-producing bacteria ensure their self-resistance before antibiotic biosynthesis incapacitates them?. Molecular Microbiology 2007, 63:937-940.
8. Hsiang Y.H., Hertzberg R., Hecht S., Liu L.F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. Journal of Biological Chemistry 1985, 260:14873-14878.
9. Kusari S., Lamshöft M., Spiteller M. Aspergillus fumigatus Fresenius, an endophytic fungus from Juniperus communis L. Horstmann as a novel source of the anticancer pro-drug deoxypodophyllotoxin. Journal of Applied Microbiology 2009, 107:1019-1030.
10. Kusari S., Lamshöft M., Zühlke S., Spiteller M. An endophytic fungus from Hypericum perforatum that produces hypericin. Journal of Natural Products 2008, 71:159-162.
11. Kusari S., Zühlke S., Kosuth J., Cellarova E., Spiteller M. Light-independent metabolomics of endophytic Thielavia subthermophila provides insight into microbial hypericin biosynthesis. Journal of Natural Products 2009, 72:1825-1835.
12. Kusari S., Zühlke S., Spiteller M. An endophytic fungus from Camptotheca acuminata that produces camptothecin and analogues. Journal of Natural Products 2009, 72:2-7.
13. Laco G.S., Collins J.R., Luke B.T., Kroth H., Sayer J.M., Jerina D.M., Pommier Y. Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model. Biochemistry 2002, 41:1428-1435.
14. Lasasso C., Cretaio E., Palle K., Pattarello L., Bjornsti M.A., Benedetti P. Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethality. Journal of Biological Chemistry 2007, 282:9855-9864.
15. van der Merwe M., Bjornsti M.A. Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin. Journal of Biological Chemistry 2008, 283:3305-3315.
16. Rasheed Z.A., Rubin E.H. Mechanisms of resistance to topoisomerase I-targeting drugs. Oncogene 2003, 22:7296-7304.
17. Sali A., Blundell T.L. Comparative modeling by satisfaction of spatial restraints. Journal of Molecular Biology 1993, 234:779-815.
18. Schrettl M., Carberry S., Kavanagh K., Haas H., Jones G.W., O'Brien J., Nolan A., Stephens J., Fenelon O., Doyle S. Self-protection against gliotoxin-a component of the gliotoxin biosynthetic cluster, GliT, completely protects Aspergillus fumigatus against exogenous gliotoxin. PLoS Pathogens 2010, 6:e1000952. (accessed 05.07.10). 10.1371/journal.ppat.1000952.
19. Sirikantaramas S., Sudo H., Asano T., Yamazaki M., Saito K. Transport of camptothecin in hairy roots of Ophiorrhiza pumila. Phytochemistry 2007, 68:2881-2886.
20. Sirikantaramas S., Yamazaki M., Saito K. Mutations in topoisomerase I as a self-resistance mechanism coevolved with the production of the anticancer alkaloid camptothecin in plants. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:6782-6786.
21. Sirikantaramas S., Yamazaki M., Saito K. A survival strategy: the coevolution of camptothecin biosynthetic pathway and self-resistance mechanism. Phytochemistry 2009, 70:1894-1898.
22. Staker B.L., Feese M.D., Cushman M., Pommier Y., Zembower D., Stewart L., Burgin A.B. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. Journal of Medicinal Chemistry 2005, 48:2336-2345.
23. Stierle A., Strobel G.A., Stierle D. Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of pacific yew. Science 1993, 260:214-216.
24. Stone J.K., Bacon C.W., White J.F. An overview of endophytic microbes: endophytism defined. Microbial Endophytes 2000, 3-29. Dekker, New York. C.W. Bacon, J.F. White (Eds.).
25. Tsurutani J., Nitta T., Hirashima T., Komiya T., Uejima H., Tada H., Syunichi N., Tohda A., Fukuoka M., Nakagawa K. Point mutations in the topoisomerase I gene in patients with non-small cell lung cancer treated with irinotecan. Lung Cancer 2002, 35:299-304.
26. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., Mcphail A.T., Sim G.A. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. Journal of the American Chemical Society 1966, 88:3888-3890.